Zenflow was founded in 2014 by a team of Stanford University Biodesign Fellows working in collaboration with top global urologists. After witnessing patients' frustration with existing treatment options, the founders made it their mission to find a better solution to this large unmet clinical need.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/07/18 | $31,400,000 | Series A |
F-Prime Capital Partners INVUS Opportunities Medical Technology Venture Partners | undisclosed |
| 11/18/24 | $24,000,000 | Series C |
Cook Medical F-Prime Capital Partners INVUS Opportunities Medical Technology Venture Partners | undisclosed |
